Home > PJ (current issue) > News / News Centre | Search

PJ Online homeThe Pharmaceutical Journal
Vol 273 No 7317 p370
18 September 2004

This article
Reprint   Photocopy

  Acrobat Reader


News summary


Latest BNF published

BNF 48, the latest edition of the British National Formulary, breaks new ground by including advice on oral and dental problems and how these relate to other problems.

According to Martin Kendall, chairman of the BNF joint formulary committee: “The advice on oral and dental conditions adds yet another dimension to the BNF and could save the patient from being referred from one practitioner to another.”

BNF 48 also includes adjustments to the BNF’s clinical advice, including:

· Updated advice on intravenous albumin solutions
· Revised advice on bronchodilators and corticosteroids in the management of chronic obstructive pulmonary disease
· Adjusted asthma charts
· Advice on measures to reduce the risk of stroke with risperidone and olanzapine

Professor Kendall added: “As usual, this new edition has taken on board important studies, guidelines and changes to the manufacturers’ product literature.”

Back to Top


©The Pharmaceutical Journal